Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro

J Immunol. 1993 Aug 15;151(4):2150-8.

Abstract

Transforming growth factor-beta (TGF-beta) has been shown to be produced in the central nervous system (CNS). The functions of TGF-beta, however, remain to be elucidated. We investigated the effects of TGF-beta on the proliferation, activation, and cytokine production of isolated microglia in vitro. TGF-beta dose-dependently suppressed the acid phosphatase activity of and formation of superoxide anion by LPS activated microglia. It also suppressed the IFN-gamma-induced expression of class II MHC Ag- and the production of cytokines, IL-1, IL-6, and TNF-alpha, by these cells. TGF-beta also inhibited the proliferation of microglia that was induced by either GM-CSF or M-CSF. Because various immunoregulatory cytokines are produced in the CNS that serve as autocrine or paracrine mediators it is suggested that TGF-beta could be a negative regulator in the CNS cytokine network. It may play a role in the development of various disease processes in the CNS by inhibiting the function of microglia in inflammation or in immunoregulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Cell Division / drug effects
  • Cells, Cultured
  • Cytokines / genetics*
  • Gene Expression / drug effects
  • Genes, MHC Class II
  • Histocompatibility Antigens Class II / genetics*
  • In Vitro Techniques
  • Mice
  • Mice, Inbred C3H
  • Molecular Sequence Data
  • Neuroglia / cytology
  • Neuroglia / physiology*
  • Oligodeoxyribonucleotides / chemistry
  • Transforming Growth Factor beta / pharmacology*

Substances

  • Cytokines
  • Histocompatibility Antigens Class II
  • Oligodeoxyribonucleotides
  • Transforming Growth Factor beta